Effective Treatment of Sleep Apnea in Prediabetes to Reduce Cardiometabolic Risk

Completed · Not applicable · Has a placebo group

Conditions studied: Diabetes, Sleep Apnea

In brief

Although obstructive sleep apnea (OSA) is associated with impaired glucose tolerance and diabetes, it remains unclear whether OSA treatment with continuous positive airway pressure (CPAP) has metabolic benefits. The objective of this study is to determine the effect of 8-hour nightly CPAP treatment on glucose metabolism in individuals with prediabetes and OSA.

Key facts

Study ID
NCT01156116
Run by
University of Chicago
People needed
39
Starts
2009-10-01
Expected to finish
2012-10-01
Last updated by the study team
2015-05-27

Who can join

Age: 45 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.